Chloroquine has been found to be effective against many viral infections in vitro through several proposed mechanisms: 1) it blocks viral replication by increasing endosomal pH required for viral fusion and uncoating, 2) it acts as a zinc ionophore inhibiting viral RNA polymerase, and 3) it modulates the immune response by reducing cytokine release. Recent studies demonstrate chloroquine can effectively inhibit SARS-CoV-2 in vitro, possibly by blocking viral entry. While chloroquine may have potential for COVID-19 treatment or prophylaxis, further randomized controlled trials are still needed to validate its risks and benefits for this application.